Literature DB >> 21351

Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.

R J O'Reilly, B Dupont, S Pahwa, E Grimes, E M Smithwick, R Pahwa, S Schwartz, J A Hansen, F P Siegal, M Sorell, A Svejgaard, C Jersild, M Thomsen, P Platz, P L'Esperance, R A Good.   

Abstract

A patient with severe combined immunodeficiency received seven transplants of bone marrow from an HLA-B-compatible and HLA-D-compatible unrelated donor in an attempt to provide immunologic reconstitution. The first four transplants achieved restricted engraftment with evidence of rudimentary immunologic function. A fifth transplant, given after low-dose cyclophosphamide, produced reconstituion of cell-mediated immunity. Marrow aplasia developed after recontamination with a nonpathogenic microflora. Transplantation of marrow previously stored in liquid nitrogen was ineffective. A subsequent transplant, administered after high-dose cyclophosphamide, achieved durable engraftment, with complete hematopoietic and immunologic reconstitution. Seventeen months after transplantation, full functional engraftment persists. Graft-versus-host disease has been chronic and moderately severe, but limited to the skin and oral mucosa. Transplantation of marrow from unrelated histocompatible donors may provide a useful treatment for patients with severe combined immunodeficiency or aplastic anemia who lack a matched sibling or related donor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 21351     DOI: 10.1056/NEJM197712152972403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

Review 1.  Hematopoietic stem cell transplantation for severe combined immune deficiency.

Authors:  K I Weinberg; N Kapoor; A J Shah; G M Crooks; D B Kohn; R Parkman
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 2.  Bone marrow transplantation: a review.

Authors:  R E Hardy; E V Ikpeazu
Journal:  J Natl Med Assoc       Date:  1989-05       Impact factor: 1.798

3.  Blood and marrow transplantation: a perspective from the University of Minnesota.

Authors:  John H Kersey
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders.

Authors:  Neena Kapoor; Revathi Raj
Journal:  Indian J Pediatr       Date:  2016-02-27       Impact factor: 1.967

Review 5.  Stem cell transplantation for primary immunodeficiency diseases: the North American experience.

Authors:  Sung-Yun Pai; Morton J Cowan
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-12

6.  Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.

Authors: 
Journal:  Blut       Date:  1980-09

7.  Treatment of severe combined immunodeficiency by transplantation.

Authors:  D Niethammer
Journal:  Blut       Date:  1981-03

8.  Bone marrow transplantation in Canada.

Authors:  N A Buskard
Journal:  Can Med Assoc J       Date:  1980-07-05       Impact factor: 8.262

9.  B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

Authors:  Alexandra M Miggelbrink; Brent R Logan; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Hisham Abdel-Azim; Susan E Prockop; David Shyr; Hélène Decaluwe; Imelda C Hanson; Alfred Gillio; Blachy J Dávila Saldaña; Hermann Eibel; Gregory Hopkins; Jolan E Walter; Jennifer S Whangbo; Donald B Kohn; Jennifer M Puck; Morton J Cowan; Linda M Griffith; Elie Haddad; Richard J O'Reilly; Luigi D Notarangelo; Sung-Yun Pai
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

Review 10.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.